Eiji Mita

8.5k total citations
120 papers, 3.3k citations indexed

About

Eiji Mita is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Eiji Mita has authored 120 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hepatology, 62 papers in Epidemiology and 25 papers in Surgery. Recurrent topics in Eiji Mita's work include Hepatitis C virus research (57 papers), Hepatitis B Virus Studies (40 papers) and Liver Disease Diagnosis and Treatment (39 papers). Eiji Mita is often cited by papers focused on Hepatitis C virus research (57 papers), Hepatitis B Virus Studies (40 papers) and Liver Disease Diagnosis and Treatment (39 papers). Eiji Mita collaborates with scholars based in Japan, United States and Italy. Eiji Mita's co-authors include Norio Hayashi, Hideyuki Fusamoto, Hideki Hagiwara, Akinori Kasahara, Takenobu Kamada, Tetsuo Takehara, Keiji Ueda, Akinori Kasahara, Takenobu Kamada and Yoshiyuki Kanazawa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Eiji Mita

109 papers receiving 3.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eiji Mita 2.4k 2.0k 540 480 275 120 3.3k
Yasuhiro Asahina 3.8k 1.6× 3.1k 1.5× 516 1.0× 576 1.2× 409 1.5× 129 4.5k
Masataka Tsuge 2.5k 1.1× 2.5k 1.2× 867 1.6× 209 0.4× 323 1.2× 189 3.9k
Mikio Nishioka 1.5k 0.6× 1.3k 0.6× 657 1.2× 539 1.1× 466 1.7× 128 2.8k
Kazumoto Murata 1.5k 0.6× 1.3k 0.6× 653 1.2× 123 0.3× 448 1.6× 135 2.7k
Haruhisa Nakao 916 0.4× 984 0.5× 338 0.6× 307 0.6× 177 0.6× 69 1.9k
Shiro Iino 2.6k 1.1× 2.7k 1.3× 319 0.6× 245 0.5× 141 0.5× 138 3.4k
Gary L. Norman 1.5k 0.6× 1.6k 0.8× 348 0.6× 1.4k 2.8× 688 2.5× 123 4.0k
Maria Grazia Rumi 4.5k 1.9× 4.2k 2.1× 256 0.5× 376 0.8× 348 1.3× 150 5.3k
Riccardo Volpes 1.9k 0.8× 1.5k 0.7× 236 0.4× 118 0.2× 254 0.9× 90 2.8k
David Booth 1.8k 0.8× 1.5k 0.7× 708 1.3× 473 1.0× 658 2.4× 35 2.9k

Countries citing papers authored by Eiji Mita

Since Specialization
Citations

This map shows the geographic impact of Eiji Mita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Mita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Mita more than expected).

Fields of papers citing papers by Eiji Mita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Mita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Mita. The network helps show where Eiji Mita may publish in the future.

Co-authorship network of co-authors of Eiji Mita

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Mita. A scholar is included among the top collaborators of Eiji Mita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Mita. Eiji Mita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamada, Yoshihiro, Shinji Takamatsu, Jumpei Kondo, et al.. (2024). Generation and validation of antibody 42B1 recognizing galactose-deficient IgG for diagnosis of chronic inflammatory diseases. Clinica Chimica Acta. 566. 120052–120052.
2.
Yamamoto, Shunsuke, Hisashi Ishida, & Eiji Mita. (2023). Purple haze: a useful sign for detecting gastric intestinal metaplasia. Gastrointestinal Endoscopy. 97(5). 987–989.
3.
Myojin, Yuta, Takahiro Kodama, Ryotaro Sakamori, et al.. (2022). Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy. Cancers. 14(4). 883–883. 57 indexed citations
4.
Hikita, Hayato, Sadatsugu Sakane, Ryohei Narumi, et al.. (2022). Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients. PLoS ONE. 17(7). e0271020–e0271020. 7 indexed citations
5.
Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2022). Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma. Hepatology Research. 52(7). 630–640. 31 indexed citations
6.
Sakamori, Ryotaro, Yuki Tahata, Teppei Yoshioka, et al.. (2022). Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller. Digestive Diseases and Sciences. 67(12). 5704–5711. 2 indexed citations
7.
Ishizaka, Aya, Michiko Koga, Taketoshi Mizutani, et al.. (2021). Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus. Viruses. 13(10). 2101–2101. 14 indexed citations
8.
Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2021). Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy. Hepatology Research. 52(3). 298–307. 27 indexed citations
9.
Kobayashi, Yuta, Kazuhiro Nishikawa, Tomofumi Akasaka, et al.. (2021). Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma. Clinical Journal of Gastroenterology. 14(2). 434–438. 3 indexed citations
10.
Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2020). Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension. Hepatology Research. 50(9). 1091–1100. 2 indexed citations
11.
Myojin, Yuta, Takahiro Kodama, Kazuki Maesaka, et al.. (2020). ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma. Clinical Cancer Research. 27(4). 1150–1161. 57 indexed citations
12.
Uehira, Tomoko, Yusuke Koizumi, Dai Watanabe, et al.. (2014). A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection. Journal of Infection and Chemotherapy. 20(9). 582–585.
13.
Tamada, Yoko, Hiroshi Yatsuhashi, Naohiko Masaki, et al.. (2011). Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B. Gut. 61(5). 765–773. 36 indexed citations
14.
Mita, Eiji, Changho Song, Takashi Ohta, et al.. (2009). A case of ectopic hepatocellular carcinoma with bone metastasis. Kanzo. 50(7). 383–389. 3 indexed citations
15.
Tanaka, Yasuhito, Hiroshi Yotsuyanagi, Koji Yano, et al.. (2009). Universal hepatitis B vaccination: pros and cons. Kanzo. 50(10). 598–604. 1 indexed citations
16.
Kaneko, Akira, Shinichiro Watanabe, Akihiro Nakama, et al.. (2005). Efficacy and problems in bezafibrate treatment for PBC. Kanzo. 46(4). 200–207. 1 indexed citations
17.
Takehara, Tetsuo, Norio Hayashi, Tomohide Tatsumi, et al.. (1999). Interleukin 1β protects mice from Fas-mediated hepatocyte apoptosis and death. Gastroenterology. 117(3). 661–668. 22 indexed citations
18.
Mita, Eiji, Norio Hayashi, Yoshiyuki Kanazawa, et al.. (1994). Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. Journal of Hepatology. 21(3). 468–473. 76 indexed citations
19.
Hagiwara, Hideki, Norio Hayashi, Akinori Kasahara, et al.. (1992). Three cases of posttransfusion hepatitis C treated with interferon-?. Digestive Diseases and Sciences. 37(4). 631–634. 5 indexed citations
20.
Hagiwara, Hideki, Norio Hayashi, Eiji Mita, et al.. (1991). Detection of hepatitis C virus RNA in serum in chronic liver disease.. Kanzo. 32(8). 762–766. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuhiro Asahina Breakdown of academic impact, for papers by Masataka Tsuge Breakdown of academic impact, for papers by Mikio Nishioka Breakdown of academic impact, for papers by Kazumoto Murata Breakdown of academic impact, for papers by Haruhisa Nakao Breakdown of academic impact, for papers by Shiro Iino Breakdown of academic impact, for papers by Gary L. Norman Breakdown of academic impact, for papers by Maria Grazia Rumi Breakdown of academic impact, for papers by Riccardo Volpes Breakdown of academic impact, for papers by David Booth
Rankless by CCL
2026